{
    "organizations": [],
    "uuid": "dd4b85990bac76c154493447d3ebcbfa8f16b6ea",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-santhera-completes-capital-increas/brief-santhera-completes-capital-increase-to-settle-obtained-license-from-polyphor-idUSASM000JKV",
    "ord_in_thread": 0,
    "title": "BRIEF-Santhera Completes Capital Increase To Settle Obtained License From Polyphor",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 22 (Reuters) - SANTHERA PHARMACEUTICALS:\n* SANTHERA COMPLETES CAPITAL INCREASE TO SETTLE OBTAINED LICENSE FROM POLYPHOR\n* SHARE CAPITAL RECORDED IN COMMERCIAL REGISTER INCREASED FROM 6,279,857 SHARES BY 247,622 SHARES TO 6,527,479 SHARES Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-02-22T14:11:00.000+02:00",
    "crawled": "2018-02-23T16:08:43.016+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "santhera",
        "pharmaceutical",
        "santhera",
        "completes",
        "capital",
        "increase",
        "settle",
        "obtained",
        "license",
        "polyphor",
        "share",
        "capital",
        "recorded",
        "commercial",
        "register",
        "increased",
        "share",
        "share",
        "share",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}